Undervalued based on future growth
Results
4
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
4 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
SQURPHARMA | ৳224.10 | 1.6% | 6.7% | ৳198.7b | ৳352.20 | 7.7 | 11.4% | 5.4% | Pharmaceuticals & Biotech | ||
BXPHARMA | ৳139.50 | -1.6% | 59.4% | ৳62.2b | ৳153.00 | 9.3 | 14.4% | 2.9% | Pharmaceuticals & Biotech | ||
RENATA | ৳446.30 | -0.2% | -8.8% | ৳51.2b | ৳615.05 | 18.7 | 30.0% | 1.2% | Pharmaceuticals & Biotech | ||
BSCPLC | ৳148.40 | 0.2% | 24.5% | ৳27.8b | ৳162.80 | 9.7 | 27.1% | 2.7% | Telecom |
Page 1 of 1